Pharmacogenomic characterisation of a large collection of patient-derived cell lines identifies novel therapeutic options for pleural mesothelioma.

This Zenodo record contains annotations of patient-derived primary pleural mesothelioma cell lines, raw drug response data from the large-scale drug screen and extension drug screen, and raw mouse survival data from the manuscript entitled “Pharmacogenomic characterisation of a large collection of patient-derived cell lines identifies novel therapeutic options for pleural mesothelioma” by Assié et al.